
Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/1479
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | "Palit A, Inamadar AC. " | - |
dc.date.accessioned | 2019-11-29T11:38:17Z | - |
dc.date.available | 2019-11-29T11:38:17Z | - |
dc.date.issued | 2014-05 | - |
dc.identifier.uri | http://hdl.handle.net/123456789/1479 | - |
dc.description.abstract | Of the various collagen vascular diseases seen in pediatric age group, discoid lupus erythematosus, systemic lupus erythematosus, neonatal lupus erythematosus, juvenile dermatomyositis and childhood scleroderma are common and of practical importance to clinicians. Various treatment modalities of these conditions have been discussed at length. Of these, some are conventional and routine,while others are used in challenging situations of these diseases. Autologous stem cell transplant, biological therapies, intravenous immunoglobulin and narrow band ultraviolet B are among the latest therapeutic options for these difficult-to-treat conditions in children. | en_US |
dc.language.iso | en | en_US |
dc.publisher | BLDE(Deemed to be University) | en_US |
dc.subject | Children, collagen vascular diseases, lupus erythematosus | en_US |
dc.title | Current treatment strategies: collagen in vascular disease in Children. | en_US |
dc.type | Article | en_US |
Appears in Collections: | Faculty of Dermatology |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.